The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer
24 minutes
Posted Jun 7, 2021 at 3:45 pm.
0:00
24:09
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Tom and Peter continue to see things differently - has the data changed things?
Previous
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
Next
Episode 109: Adjuvant pembrolizumab in renal cancer
← See all 501 episodes of The Uromigos